Editorial
doi: 10.1086/651697.
Adherence in HIV type 1 prevention trials
- PMID: 20235837
- DOI: 10.1086/651697
Item in Clipboard
Editorial
Adherence in HIV type 1 prevention trials
J Infect Dis.
.
No abstract available
Comment on
-
Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial.J Infect Dis. 2010 May 1;201(9):1285-97. doi: 10.1086/651696. J Infect Dis. 2010. PMID: 20235836 Free PMC article. Clinical Trial.
Similar articles
-
Reassessing the hypothesis on STI control for HIV prevention.Lancet. 2008 Jun 21;371(9630):2064-5. doi: 10.1016/S0140-6736(08)60896-X. Lancet. 2008. PMID: 18572064 No abstract available.
-
AIDS research. Promising prevention interventions perform poorly in trials.Science. 2007 Jul 27;317(5837):440. doi: 10.1126/science.317.5837.440. Science. 2007. PMID: 17656693 No abstract available.
-
Treating HIV infection with drugs for HSV-2 infection?Lancet. 2010 Mar 6;375(9717):782-4. doi: 10.1016/S0140-6736(10)60097-9. Epub 2010 Feb 12. Lancet. 2010. PMID: 20153889 No abstract available.
-
Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research.Curr HIV/AIDS Rep. 2008 Nov;5(4):186-92. doi: 10.1007/s11904-008-0027-z. Curr HIV/AIDS Rep. 2008. PMID: 18838058 Review.
-
Recent developments in the management of herpes simplex virus infection in HIV-infected persons.Clin Infect Dis. 2004 Nov 1;39 Suppl 5:S237-9. doi: 10.1086/422360. Clin Infect Dis. 2004. PMID: 15494894 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
